Healthtech Startups

Cresco Labs is a vertically integrated cannabis producer and retailer that cultivates, manufactures, and distributes cannabis products through national brands and Sunnyside dispensaries. The company operates cultivation and manufacturing facilities, wholesale distribution, and a retail network focused on quality, consumer education, and brand building in the legal cannabis market.

2 investors

CrossBridge Bio, launched in 2023, develops next-generation antibody-drug conjugates (ADCs) to address a range of cancer indications. The company originated from ADC technology developed at the University of Texas Health Science Center at Houston.

2 investors

Crossover Health operates an integrated primary care delivery model centered on member experience, using proprietary technology and care structures to expand healthcare access and accountability. The company serves patients and employer groups seeking preventative and primary care outside traditional healthcare system navigation.

2 investors

CrowdHealth offers a community-based approach to health care funding, where members help cover each other's medical bills as an alternative to traditional health insurance. It presents itself as a health-focused service for individuals and families.

2 investors

Cryosa develops an incisionless medical treatment that uses controlled cooling to reduce tissue and open airways. The company serves patients requiring airway management procedures.

2 investors

CryoVeritas makes user-activated temperature indicators that integrate both time and temperature to confirm the integrity of vaccines and biospecimens exposed to heat during cold-chain storage down to −200 °C. Its "Pinktail" indicators are tunable from 5 minutes to 48+ hours and serve biorepositories, IVF/reproductive tissue banks, cell therapy, mRNA vaccine, blood banking, and forensic storage applications.

2 investors

CSafe develops temperature-controlled shipping solutions for the pharmaceutical and life sciences cold chain, including active and passive air cargo containers, parcel shippers, and cryogenic dewars for cell and gene therapies. It serves biopharma logistics worldwide with a network of service centers, manufacturing facilities, and real-time tracking technology.

2 investors

CU Anschutz is an academic medical campus focused on health professions education, biomedical research, and patient care across areas such as cancer, heart disease, Alzheimer's, and COVID-19. It trains future health professionals and conducts sponsored and philanthropically funded research.

2 investors

Cubtale provides a digital platform that helps parents capture and organize routine childcare data, share information with health professionals, and track developmental milestones. The service delivers personalized insights to improve parental caregiving.

2 investors

CuePath makes smart adhesive stickers (CuePack) that attach to standard medication blister packs, recording when each blister is opened and syncing that adherence data to the cloud and clinical trial management systems such as REDCap. The product serves clinical researchers and contract research organizations running distributed, placebo-controlled drug trials, particularly for controlled substances and substance use disorder treatment.

2 investors

Cullgen is a privately held biopharmaceutical company developing first-in-class drugs based on its uSMITE™ (small-molecule induced ubiquitin-dependent target elimination) targeted protein degradation platform, which uses the ubiquitin-proteasome system and E3 ubiquitin ligases to target disease-causing proteins that conventional small-molecule drugs cannot reach. The company focuses on oncology and immune-related diseases and operates R&D and offices in both China and the United States.

2 investors

Cullinan Therapeutics is a clinical-stage biotech company developing therapeutic molecules for autoimmune diseases and cancer, with expertise in immune modulation. The company focuses on first- or best-in-class treatments to improve outcomes for patients managing these conditions.

2 investors

NeuLogiq is a research platform for clinical trials that integrates tablet-based cognitive assessments, EEG monitoring, and real-world behavioral data to measure brain function changes. The platform serves biopharma sponsors and clinical research sites conducting central nervous system studies across phases 0-3.

2 investors

Curavit designs and executes decentralized clinical trials using technology to improve patient outcomes and trial efficiency for pharmaceutical and medical device companies.

2 investors

CureBay is an online healthcare platform in India offering genuine medicine delivery, lab test bookings, and doctor consultations. It serves consumers seeking affordable access to healthcare services.

2 investors

Cure Genetics develops two biotechnology platforms: AIMS CAR-NKT, a cell therapy targeting solid tumors such as clear cell renal carcinoma, and the VELP directed-evolution library platform for gene therapy applications addressing the nervous system, heart, and kidneys. Its VELP platform has licensing collaborations with pharmaceutical companies including Boehringer Ingelheim.

2 investors

Curejoy is a digital health and wellness content platform that aggregates information about natural health practices and home remedies for a global audience. It serves health-conscious consumers seeking credible wellness information and expert advice through its website, social media, and newsletters.

2 investors

CurieDx is a screening tool that provides a patient screening interface and provider workflow for medical practices, offered to clinicians across specialties. It is delivered as a diagnostic software product for healthcare providers.

2 investors

Curoflow provides a white-label digital healthcare platform for care providers, combining booking, triage, electronic medical records, a patient portal, payments, and business support in one system. Built for the European market with local hosting and GDPR/PDL compliance, it serves clinics and larger care chains.

2 investors

CurveBeam AI develops point-of-care cone beam CT imaging systems combined with AI and deep learning tools for orthopedic and bone health applications, including fragility fracture prevention. The company serves orthopedic and podiatric healthcare providers seeking diagnostic imaging and complementary software solutions.

2 investors

CustoMED develops an AI-powered platform for personalized surgery that enables hospitals and 3D labs to scale surgical customization with reduced manual labor and cost.

2 investors

Cyberdyne develops HAL, a wearable cyborg exoskeleton that detects bioelectric signals from the wearer's muscles and assists or augments physical movement. The technology is applied across medical, healthcare, caregiving, industrial, construction, and disaster recovery sectors.

2 investors

Cybrexa is a biotechnology company developing cancer therapeutics that use its alphalex peptide-drug conjugate platform to target the low-pH tumor microenvironment for selective delivery. The technology aims to enable more potent drugs and combination therapies and to expand the efficacy of existing anticancer agents.

2 investors

CyGenica develops a targeted intracellular drug delivery technology, the GEENIE platform, to deliver therapeutic molecules into cells more safely and efficiently. Its work focuses on treatments for oncology and rare genetic diseases, serving biopharmaceutical companies developing therapies.

2 investors